Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E6ME
|
||||
Former ID |
DIB013554
|
||||
Drug Name |
GED-0507-34-Levo
|
||||
Synonyms |
GED-0507; GED-0507-34; GED-0507-34E2
|
||||
Indication | Inflammatory bowel disease [ICD9: 555, 556; ICD10:K50, K51] | Phase 2 | [549154] | ||
Company |
Giuliani SpA
|
||||
Structure |
Download2D MOL |
||||
Target and Pathway | |||||
Target(s) | Peroxisome proliferator activated receptor gamma | Target Info | Agonist | [532345] | |
PANTHER Pathway | CCKR signaling map ST | ||||
WikiPathways | Wnt Signaling Pathway Netpath | ||||
Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
Differentiation of white and brown adipocyte | |||||
Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | |||||
Transcriptional Regulation of White Adipocyte Differentiation | |||||
Adipogenesis | |||||
SREBP signalling | |||||
Nuclear Receptors | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.